← Back to headlines
Eli Lilly Shares Climb on Stronger Revenue Outlook Driven by Obesity Drugs
Eli Lilly's stock saw a significant increase after the company released a stronger revenue outlook, primarily attributed to the strong performance and future potential of its obesity drug portfolio.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Construction Begins on Challenging New Highway Linking Skopje to Kosovo
19m ago
SolarEdge Stock Surges After UBS Upgrade Citing Inverter Import Ban
35m ago
RedBird Capital Advances Talks to Acquire Stake in Puck Media
37m ago
Meta Agrees to $18 Billion Settlement Over Alleged Social Media Harm to Children
40m ago